Latest 8-K filings

Quest Resource Holding Corporation reported Q2 2026 results with revenue increasing 7.6% year-over-year to $64.1 million, but a substantial goodwill impairment charge led to a net loss of $12.2 million.

Corvus Pharmaceuticals provided a business update and reported second quarter 2026 financial results, highlighting progress in soquelitinib trials and a strong cash position extending runway into mid-2028.

Omada Health announced robust Q2 2026 financial results, including 43% year-over-year revenue growth and a shift to net income, alongside a planned CEO transition.

Nephros, Inc. announced record second-quarter net revenue of $6 million, a 36% increase year-over-year, alongside a significant jump in net income to $1.2 million.

Nerdy Inc. announced the wind-down of its Varsity Tutors for Schools offering to concentrate on its core Consumer business, estimating exit costs between $2 million and $4 million.

TriSalus Life Sciences announced Q2 2026 results, with revenue of $11.4 million and maintained full-year guidance of $54-$57 million, despite increased operating losses driven by sales expansion.

TTM Technologies announced record-breaking second quarter 2026 results, with sales surpassing $1 billion for the first time and non-GAAP EPS reaching $0.99, both exceeding prior guidance.

Accuray Incorporated has received Nasdaq approval to transfer its common stock listing from the Global Select Market to the Capital Market, effective August 6, 2026, while also being granted an extension to meet bid price requirements.

Consensus Cloud Solutions announced Q2 2026 results, showing a 4.1% revenue increase to $91.4 million, driven by corporate channel growth, and reaffirmed full-year guidance while increasing its stock buyback program.

Renasant Corporation presented its Q2 2026 results, showcasing steady loan growth, a significant subordinated debt offering, and increased dividends, while managing deposit fluctuations and a slight NIM compression.

Lee Enterprises announced preliminary third quarter fiscal 2026 results, showcasing a 23% year-over-year increase in Adjusted EBITDA and a return to net income, leading to an improved fiscal 2026 outlook.

Ensysce Biosciences has acquired Cy Biopharma, gaining a clinical-stage therapy for CRPS and securing up to $77 million in private financing to advance its pipeline.

DXP Enterprises announced robust second quarter 2026 results, showcasing a 15.6% increase in sales to $576.5 million and a 22.8% rise in Adjusted EBITDA to $70.4 million.

Trinseo PLC announced its second quarter 2026 financial results, reporting an $845 million net sales increase but a $120 million net loss, impacted by restructuring charges and ongoing debt negotiations.

American Realty Investors, Inc. announced a net loss of $1.0 million for Q2 2026, a reversal from a $2.8 million net income in the prior year, driven by increased operating expenses.

Transcontinental Realty Investors, Inc. announced its Q2 2026 results, reporting a net loss of $1.1 million ($0.13 per share) compared to a net income of $0.2 million ($0.02 per share) in the prior year period.

International Bancshares Corporation announced solid first-half 2026 net income of $198.0 million, driven by portfolio growth and favorable interest rate environments, despite a quarterly dip in net income.

IEH Corporation reported a cybersecurity incident on August 4, 2026, involving unauthorized access to an employee's Microsoft 365 mailbox.

Income Opportunity Realty Investors, Inc. announced its operational results for the quarter ended June 30, 2026, reporting a decrease in net income attributable to common shares.

Willis Lease Finance Corporation has entered into an agreement to acquire three commercial buildings in Coconut Creek, Florida, for $118.0 million to support its expanding operations.

The Southern Company has issued Series 2026A and 2026B Convertible Senior Notes, totaling over $2.7 billion, to fund its operations and manage its capital structure.

STAAR Surgical announces the permanent appointment of Warren Foust as CEO and details new executive compensation packages, including performance-based stock options tied to significant stock price hurdles.

CreditRiskMonitor.com, Inc. announced it will restate previously issued financial statements due to errors in sales and income tax collection and remittance, leading to a material weakness in internal controls.

Sempra announced robust second-quarter 2026 financial results, with GAAP earnings of $796 million ($1.21 per diluted share) and adjusted earnings of $762 million ($1.16 per diluted share), demonstrating significant year-over-year growth.

Sempra announced robust second-quarter 2026 financial results, with GAAP earnings of $796 million ($1.21 per diluted share) and adjusted earnings of $762 million ($1.16 per diluted share), demonstrating significant year-over-year growth.

Alpha Pro Tech, Ltd. announced a 12% increase in Q2 2026 net sales to $18.7 million and a 47% surge in net income to $1.8 million, driven by strong performance in protective apparel and building products.

Whitehawk Therapeutics announced Q2 2026 results, highlighting continued enrollment in Phase 1 trials for HWK-007 and HWK-016, with HWK-206 initiation on track for Q3 2026, and an extended cash runway into 2H 2028.

Digital Brands Group has retained a financial advisor to explore take-private options and has received a significant all-cash acquisition proposal from a major shareholder.

MSC Income Fund, Inc. announced its regular monthly cash dividends for the fourth quarter of 2026 and a supplemental dividend payable in December 2026.

Regency Centers Corporation announced its Board of Directors has declared quarterly cash dividends for its common stock and Series A and Series B preferred stock.